Fukuda Denshi Co Ltd
TSE:6960
Fukuda Denshi Co Ltd
TSE:6960
Price:
6 070 JPY
-1.78%
Market Closed
Updated:
May 22, 2024
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
3.3
Current
2.1
Median
13.1
Industry
Higher
than median
Lower
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=3.3
Enterprise Value
/
119.6B
EBITDA
36.7B
All Countries
| Market Cap | EV/EBITDA | ||||
|---|---|---|---|---|---|
| JP |
|
Fukuda Denshi Co Ltd
TSE:6960
|
183.6B JPY | 3.3 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
179.1B USD | 18.8 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
142B USD | 58.7 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.7B USD | 24.3 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
113.2B USD | 14.3 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
111.5B USD | 31.7 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
68.2B USD | 18.1 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
59.8B EUR | 18.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
54.2B USD | 27.9 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
51.9B USD | 60.6 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
369.4B CNY | 27.9 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
3.8
2-Years Forward
EV/EBITDA
3.6
3-Years Forward
EV/EBITDA
3.3
You don't have any saved screeners yet
